fluorobenzenes has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barus, R; Gautier, S; Jouvray, M; Potey, C | 1 |
| Elisaf, MS; Kostapanos, MS; Rizos, CV | 1 |
| Hussar, DA | 1 |
| Guthrie, RM | 1 |
2 review(s) available for fluorobenzenes and Adverse Drug Event
| Article | Year |
|---|---|
Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.
Topics: Atherosclerosis; Cholesterol, LDL; Drug-Related Side Effects and Adverse Reactions; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Sulfonamides | 2014 |
How safe is aggressive statin therapy?
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Muscular Diseases; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
2 other study(ies) available for fluorobenzenes and Adverse Drug Event
| Article | Year |
|---|---|
Rosuvastatin-Induced Dysarthria: An Unusual Drug Reaction.
Topics: Drug-Related Side Effects and Adverse Reactions; Dysarthria; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rosuvastatin Calcium; Sulfonamides | 2022 |
New drugs 04. Part III.
Topics: Adrenergic alpha-Antagonists; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Aprepitant; Boronic Acids; Bortezomib; Drug Approval; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Fluorobenzenes; Glucans; Glucose; Glucosylceramidase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Icodextrin; Immunosuppressive Agents; Isoquinolines; Morpholines; Nurse's Role; Omalizumab; Palonosetron; Patient Education as Topic; Pyrazines; Pyrimidines; Quinazolines; Quinuclidines; Rosuvastatin Calcium; Sulfonamides | 2004 |